Results
|
|
1.
|
|
|
|
2.
|
Non-influence of lipid lowering therapy in atrial fibrillation recurrence. MedStar authors:
Year: 2013
Citation: - International Journal of Cardiology. 168(5):5006-7, 2013 Oct 12.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Letter
- Randomized Controlled Trial
All authors: - Arora S, Badheka AO, Bhalaria V, Chothani A, Deshmukh A, Grover PM, Khalpada D, Mehta K, Mitrani RD, Nalluri N, Panaich SS, Parmar NG, Patel N, Patel NJ, Rathod A, Savani GT, Shah N, Singh V, Viles-Gonzalez JF
|
|
|
3.
|
Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation. MedStar authors:
Year: 2020
Citation: - American Journal of Medicine. 133(12):1460-1470, 2020 12.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ahmed A, Allman RM, Anker MS, Arundel C, Deedwania P, Faselis C, Fonarow GC, Karasik PA, Lam PH, Moore H, Morgan CJ, Singh S, Tummala L, Wopperer S, Zeng Q
|
|
|
4.
|
Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function. MedStar authors:
Year: 2013
Citation: - International Journal of Cardiology. 169(5):e84-6, 2013 Nov 20.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
All authors: - Arora S, Badheka AO, Bhalara V, Chothani A, Deshmukh A, Grover PM, Hoosien M, Khalpada D, Lafferty J, Mehta K, Mitrani RD, Patel N, Patel NJ, Rathod A, Savani GT, Shah N, Singh V, Vazzana TJ, Viles-Gonzalez JF
|
|
|
5.
|
Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM Trial). MedStar authors:
Year: 2014
Citation: - American Journal of Cardiology. 114(5):727-36, 2014 Sep 1.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Arora S, Badheka AO, Chothani A, Deshmukh AJ, Grover PM, Lafferty J, Marzouka GR, Mehta JL, Mehta K, Mitrani RD, Patel N, Patel NJ, Rathod A, Savani GT, Shah N, Singh V
|
|
|
6.
|
Albumin and bleed risk in rivaroxaban treated patients. MedStar authors:
Year: 2020
Citation: - Journal of Thrombosis & Thrombolysis. 50(4):1004-1011, 2020 Nov.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Chen L, Cheruvil C, Hassan A, Holsen MR, Rossi M, Wilcox N, Wojakowski E
|
|
|
7.
|
|
